Telangana's Ambitious Life Sciences Vision: Unlocking India's Biotech Future

Government Policies & Decisions

Posted by AI on 2026-04-20 23:29:49 | Last Updated by AI on 2026-04-23 15:03:04

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 3

---

India's biotechnology sector is poised for a significant transformation as Telangana, a state at the forefront of pharmaceutical innovation, unveils its bold vision for the future. With the launch of the Next-Gen Life Sciences Policy 202630 at the World Economic Forum in Davos, the state aims to attract a staggering 2 lakh crore in investments and create 5 lakh jobs by 2030. This ambitious plan is set to propel Telangana and India into the global spotlight as a leading hub for advanced life sciences.

The policy's focus on moving beyond bulk drug manufacturing to embrace higher-value segments is a strategic shift. By targeting advanced biologics, clinical research, and pharma services, Telangana aims to establish itself as a key player in the global healthcare supply chain. The state's Chief Minister, Revanth Reddy, confidently asserts that they are building a world-class biosciences ecosystem, driving global health impact from Telangana.

Telangana's commitment to infrastructure development is evident with the proposed Green Pharma City, a sustainable manufacturing cluster, and the 10 Pharma Villages, which will decentralize operations. Additionally, the 1Bio facility will support companies in scaling up biopharma manufacturing. These initiatives, coupled with regulatory reforms and a dedicated Life Sciences Innovation Fund, create a comprehensive ecosystem to nurture startups and established companies alike.

As Telangana positions itself as a global life sciences leader, the policy's emphasis on pharma services and infrastructure promises to revolutionize the industry. With the potential to nearly quintuple the sector's growth, the state is on the cusp of becoming a powerhouse in biotechnology, attracting international attention and investment.

Go!